Search Browse Earnings

AtaiBeckley Inc. — SlamSEC

AtaiBeckley Inc.

Pharmaceutical Preparations·NEW YORK, NY

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$308,000

FY 2025

Adj. EBITDA

-$102.2M

-33187.7% margin

FY 2025

Net Income

-$149.3M

-48464.0% margin

FY 2025

EPS (Diluted)

-$0.93

FY 2025

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$17.5M

FY 2025

Total Debt

$149.5M

FY 2025

Net Debt

$132.0M

FY 2025

Enterprise Value

—

Debt / EBITDA

-1.3x

FY 2025

EV / EBITDA

—

Employees

—